VANGUARD GROUP INC 13D and 13G filings for Ginkgo Bioworks Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 6:36 pm Sale | 2026-03-13 | 13G | GINKGO BIOWORKS HLDGS INC DNA | VANGUARD GROUP INC | 0 0.000% | -2,381,115 (Position Closed) | Filing |
| 2025-07-29 1:34 pm Purchase | 2025-06-30 | 13G | GINKGO BIOWORKS HLDGS INC DNA | VANGUARD GROUP INC | 2,381,115 5.130% | 367,567 (+18.25%) | Filing |
| 2025-01-30 9:58 pm Sale | 2024-12-31 | 13G | GINKGO BIOWORKS HLDGS INC DNA | VANGUARD GROUP INC | 2,013,548 4.450% | -592,205 (-22.73%) | Filing |
| 2024-11-12 3:58 pm Unchanged | 2024-09-30 | 13G | GINKGO BIOWORKS HLDGS INC DNA | VANGUARD GROUP INC | 2,605,753 6.040% | 0 (Unchanged) | Filing |
| 2024-11-04 11:56 am Sale | 2024-09-30 | 13G | GINKGO BIOWORKS HLDGS INC DNA | VANGUARD GROUP INC | 2,605,753 6.040% | -713,739 (-21.50%) | Filing |